Research summary ·
Association between triglyceride-glucose index (TyG) as a surrogate marker of insulin resistance and risk of gestational diabetes mellitus (GDM): updated systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This study pooled the results of earlier studies on diabetes in pregnancy. It looked at a blood marker called the TyG index. Its name comes from triglyceride and glucose. The team asked if this marker, taken in the first trimester, could flag later diabetes. All studies were cohort studies of adult women carrying one baby.
What they found
The review included 462,233 pregnant women. Of these, 30,875 women got diabetes during pregnancy. A high TyG value early on was linked to higher odds of this diabetes. The link held when the team left out studies that swayed the results. It also held in Asian groups and in the more sound studies. The authors rated the marker's test accuracy as moderate.
What it means for patients
The authors say high TyG is tied to a higher risk of this diabetes. They say it may help sort women by risk early in pregnancy. But they say it is not accurate enough as a test on its own.
Why it is not certain yet
The results varied a lot between the studies. Studies used different cut-off values to call TyG high. All studies were observational, so they show links, not cause. Few studies came from outside Asia. A review can only be as good as the studies in it.
Source
Association between triglyceride-glucose index (TyG) as a surrogate marker of insulin resistance and risk of gestational diabetes mellitus (GDM): updated systematic review and meta-analysis.
PubMed · PMID 42924394We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Gestational diabetes publications